Does Dr. RAVINDER DAHIYA have financial conflicts of interest?

Dr. RAVINDER DAHIYA (MD) has received a total of $2,697 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,697 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RAVINDER DAHIYA?

According to CMS Open Payments data, Dr. RAVINDER DAHIYA received funding from MERZ NORTH AMERICA ($1,509), GALDERMA LABORATORIES, L.P ($586), and LUMENIS BE ($274).

Does Dr. RAVINDER DAHIYA receive research grants or speaking fees?

Dr. RAVINDER DAHIYA has received $2,697 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RAVINDER DAHIYA

MDReal-Time Hydrated

Specialty: Otolaryngology, Otolaryngology/Facial Plastic Surgery

Practice Location: ROCKVILLE, MD 20850

NPI Number: 1568659464

LIFETIME INDUSTRY VALUE

$2,697

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. DAHIYA is a verified Otolaryngology, Otolaryngology/Facial Plastic Surgery practitioner based in ROCKVILLE, MD.

Between 2021 and 2024, Dr. DAHIYA had an overall industry promotional and research financial footprint of $2,697 as recorded in the federal CMS Open Payments database.

$2,697 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. DAHIYA's primary funding source is MERZ NORTH AMERICA, which accounts for $1,509 (representing 56% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

MERZ NORTH AMERICA

Rank 1

$1,509

56%

GALDERMA LABORATORIES, L.P

Rank 2

$586

21.7%

LUMENIS BE

Rank 3

$274

10.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.